Industries > Pharma > The Global Respiratory Inhalers Market 2018-2028

The Global Respiratory Inhalers Market 2018-2028

Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others

PUBLISHED: 24 October 2018
PAGES: 165
PRODUCT CODE: PHA0337
SUBMARKET: Medical Devices

Clear
WOOCS 2.2.1
SKU: PHA0337 Categories: , Tags: , , , ,

The global respiratory inhalers market reached $33bn in 2017 and is estimated to reach $38bn by 2023. In 2017, the asthma segment held 58% of the global respiratory inhalers market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 165-page report you will receive 121 charts– all unavailable elsewhere.

The 165-page report provides clear detailed insight into the respiratory inhalers market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Global Respiratory Inhalers Market from 2018-2028

• Forecast of the Global Respiratory Inhalers market by Type of Product:
• Metered Dose Inhalers (MDIs)
• Dry Powder Inhalers (DPIs): Single-dose DPIs, Multi-dose DPIs
• Nebulizers: Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers

• Forecast of the Global Respiratory Inhalers market by Indication:
• Asthma
• COPD
• Other Respiratory Diseases

The Global Respiratory Inhalers Market 2018-2028

• This report provides individual revenue forecasts to 2028 for these national markets:
• The US
• Germany
• France
• UK
• Italy
• Spain
• Japan
• China
• India
• Russia
• Brazil
• Mexico
• Canada

• Our study discusses the selected leading companies that are the major players in the respiratory inhalers market:
• AstraZeneca
• Boehringer Ingelheim
• Chiesi Farmaceutici S.p.A.
• GlaxoSmithKline (GSK)
• Merck & Co.
• Novartis
• Teva

• This report discusses factors that drive and restrain this market. As well as opportunities and challenges faced by this market.

• This report discusses the Porter’s Five Forces Analysis of the respiratory inhalers market.

Visiongain’s study is intended for anyone requiring commercial analyses for the respiratory inhalers market. You find data, trends and predictions.

Buy our report today The Global Respiratory Inhalers Market Analysis : Dry Powder Inhalers, Single-dose DPI, Multi-dose DPI, Metered Dose Inhalers, Nebulizers, Jet Nebulizers, Ultrasonic Nebulizers, Vibrating-mesh Nebulizers, Asthma, COPD, Others.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for The Global Respiratory Inhalers Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for The Global Respiratory Inhalers Market 2018-2028


Latest Pharma news

Visiongain Publishes Cancer Diagnostics Market Report 2021-2031

Major investments have been made by companies in the cancer diagnostics industry in the past few years to develop novel tests to capitalize on the opportunities in the untapped market.

19 April 2021

READ

Visiongain Publishes Food for Special Medical Purpose (FSMP) Market Report 2020-2030

The food for special medical purpose (FSMP) market growth can be attributed to the growing prevalence of metabolic diseases, growing consumer unhealthy lifestyle, and surge in demand from emerging economies such as Asia Pacific, Middle East & Africa, Latin America, and others.

12 April 2021

READ

Visiongain Publishes Cell-Based Assays Market Report to 2030

Growing incidence of chronic diseases; increasing R&D investment for drug discovery research and Growing Adoption of High-Throughput Screening Methodologies are some of the major factors that propel the market growth.

09 April 2021

READ

Visiongain Publishes Cancer Biologics Therapies Market Report 2021-2031

The main drivers for the growth include technological advancements in the development of novel biomarkers, rising preference for minimally or less invasive surgeries, increasing cancer awareness leading to growth in cancer cases, and growing disposable income in emerging economies.

06 April 2021

READ

Categories